Ying Yuan

机构：Second Affiliated Hospital of Zhejiang University · ORCID：0009-0002-3203-3387

发表论文 31 篇 · 总被引 245 次 · h-index 11

代表论文

• Potential diagnostic markers and therapeutic targets for rheumatoid arthritis with comorbid depression based on bioinformatics analysis (2023 · Frontiers in Immunology · 被引 32)
• Nimotuzumab combined with gemcitabine versus gemcitabine in K-RAS wild-type locally advanced or metastatic pancreatic cancer: A prospective, randomized-controlled, double-blinded, multicenter, and phase III clinical trial. (2022 · Journal of Clinical Oncology · 被引 29)
• Plant protein-derived anti-breast cancer peptides: sources, therapeutic approaches, mechanisms, and nanoparticle design (2025 · Frontiers in Pharmacology · 被引 25)
• Anti-breast cancer effects of dairy protein active peptides, dairy products, and dairy protein-based nanoparticles (2024 · Frontiers in Pharmacology · 被引 19)
• A first-in-human phase I/II study of GFH375, a highly selective and potent oral KRAS G12D inhibitor in patients with KRAS G12D mutant advanced solid tumors. (2025 · Journal of Clinical Oncology · 被引 14)
• A phase 2 trial of sintilimab (IBI 308) in combination with CAPEOX and bevacizumab (BBCAPX) as first-line treatment in patients with RAS-mutant, microsatellite stable, unresectable metastatic colorectal cancer. (2022 · Journal of Clinical Oncology · 被引 14)